Ignite Creation Date:
2025-12-24 @ 2:51 PM
Ignite Modification Date:
2026-01-24 @ 4:01 AM
Study NCT ID:
NCT00268359
Status:
COMPLETED
Last Update Posted:
2014-07-21
First Post:
2005-12-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas
Sponsor:
Duke University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Pro00004091
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |